ARPA-H is seeking proposals from experts in surgery, imaging and AI, including academic and scientific research institutions ...

Most AI drug development is fueled by foundation models in biology—models that are trained on vast biological data sets and ...

The FDA has delayed a decision on Ascendis Pharma’s dwarfism drug candidate TransCon CNP, pushing back the deadline by three ...

In what Ceribell is hailing as a first of its kind, the company received a 510 (k) clearance from the FDA for its Clarity ...

French vaccine developer Valneva is closing down a site that houses both operational and R&D work, impacting 30 employee roles. | French vaccine maker Valneva is closing down a site that houses both ...

Hologic has put forward two studies of its artificial intelligence programs for mammography, showing that an AI tool could maintain high breast cancer detection rates while also simplifying radiolo | ...

AbbVie is opening submissions for an award that will provide one Canadian biotech with free access to lab space and executive ...

The Federal Trade Commission (FTC) has begun outlining its case against Edwards Lifesciences' proposed purchase of heart ...

As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having ...

VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugs—a mission that ...

A drug safety group has delivered a positive analysis for a Sarepta Therapeutics-licensed RNA medicine, with the same study ...

Swedish biotech Sprint Bioscience is selling off an early-stage TREX1 cancer program to Gilead for $14 million upfront, plus ...